Organon & Co reported $1.48B in Trade Debtors for its fiscal quarter ending in September of 2026.





Trade Debtors Change Date
Bristol-Myers Squibb USD 12.85B 976M Sep/2026
Celltrion KRW 2.37T 360.25B Jun/2026
Cspc Pharmaceutical CNY 8.79B 64.64M Dec/2025
Deva Holding AS TRY 3.03B 343.23M Sep/2023
Dianthus Therapeutics USD 106K 1.12M Jun/2026
Divis Laboratories Ltd INR 34.87B 4.88B Sep/2026
Gilead Sciences USD 5.06B 314M Jun/2026
Glaxosmithkline GBP 11.31B 814.23M Sep/2026
Kangmei Pharma CNY 2.86B 60.36M Jun/2026
Knight Therapeutics CAD 183M 7.46M Dec/2025
Laboratorios Farma EUR 143.38M 16.93M Dec/2023
Malin Corporation EUR 500K 300K Dec/2024
Medical Developments International AUD 7.48M 174K Dec/2025
Merck USD 12.56B 354M Jun/2026
Neuren Pharmaceuticals AUD 26.54M 5.83M Dec/2025
Novartis USD 9.96B 361M Sep/2026
Organigram Holdings CAD 88.6M 35.22M Jun/2026
Organon & Co USD 1.48B 12M Sep/2026
Ovoca Bio EUR 53K 14K Dec/2025
Pharma Mar EUR 64.12M 6.06M Sep/2026
Qiagen NV USD 398.35M 1.73M Jun/2026
Sartorius EUR 419.8M 38.6M Sep/2026
Sino Biopharmaceutical CNY 8.45B 3.18B Jun/2025
Tilray USD 109.07M 2M Sep/2025
Zealand Pharma A/S 259M 81M Mar/2026